Heparin Strongly Induces Soluble Fms-Like Tyrosine Kinase 1 Release In Vivo and In Vitro—Brief Report

Modulation of Trophoblast Angiogenic Factor Secretion by Antiphospholipid Antibodies is Not Reversed by Heparin

(2011) Tamara Y. Carroll et al.   AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY

Local Retention Versus Systemic Release of Soluble VEGF Receptor-1 Are Mediated by Heparin-Binding and Regulated by Heparanase

(2011) Shay Sela et al.   CIRCULATION RESEARCH

Elevated Soluble fms-Like Tyrosine Kinase-1 Levels in Acute Coronary Occlusion

(2010) Navin K. Kapur et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Usefulness of Soluble Fms-like Tyrosine Kinase-1 as a Biomarker of Acute Severe Heart Failure in Patients With Acute Myocardial Infarction

(2009) Kenji Onoue et al.   AMERICAN JOURNAL OF CARDIOLOGY

Phase I/II Trial of Metronomic Chemotherapy With Daily Dalteparin and Cyclophosphamide, Twice-Weekly Methotrexate, and Daily Prednisone As Therapy for Metastatic Breast Cancer Using Vascular Endothelial Growth Factor and Soluble Vascular Endothelial Growth Factor Receptor Levels As Markers of Response

(2009) Nan Soon Wong et al.   JOURNAL OF CLINICAL ONCOLOGY

A Novel Human-Specific Soluble Vascular Endothelial Growth Factor Receptor 1

(2008) Shay Sela et al.   CIRCULATION RESEARCH